Informationen:
Fehler:
ID
28486
Beschreibung
Effect of Abrupt Plavix® Discontinuation on Platelet Function; ODM derived from: https://clinicaltrials.gov/show/NCT00670943
Link
https://clinicaltrials.gov/show/NCT00670943
Stichworte
Versionen (1)
- 17.01.18 17.01.18 -
Rechteinhaber
See clinicaltrials.gov
Hochgeladen am
17. Januar 2018
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Coronary Artery Disease NCT00670943
Eligibility Coronary Artery Disease NCT00670943
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Coronary Artery Disease NCT00670943
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Coronary Artery Disease Stable | Clopidogrel To be stopped | Placement of stent
Item
group 1: patients suffering from stable cad scheduled to discontinue clopidogrel therapy at least one month after stent implantation
boolean
C1956346 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
C0070166 (UMLS CUI [2,1])
C1272691 (UMLS CUI [2,2])
C0522776 (UMLS CUI [3])
C0205360 (UMLS CUI [1,2])
C0070166 (UMLS CUI [2,1])
C1272691 (UMLS CUI [2,2])
C0522776 (UMLS CUI [3])
Coronary Artery Disease Stable | Clopidogrel naive
Item
group 2: stable clopidogrel-naïve cad patients
boolean
C1956346 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
C0070166 (UMLS CUI [2,1])
C0919936 (UMLS CUI [2,2])
C0205360 (UMLS CUI [1,2])
C0070166 (UMLS CUI [2,1])
C0919936 (UMLS CUI [2,2])
Informed Consent
Item
patients willing to participate in the study and to sign the informed consent form
boolean
C0021430 (UMLS CUI [1])
Acute Coronary Syndrome | Revascularization
Item
acute coronary syndrome or revascularization in the last 3 months prior to enrolment
boolean
C0948089 (UMLS CUI [1])
C0581603 (UMLS CUI [2])
C0581603 (UMLS CUI [2])
Anti-Inflammatory Agents, Non-Steroidal | Cyclooxygenase 2 Inhibitors | Ticlopidine | Dipyridamole | Warfarin | Acenocoumarol
Item
concurrent ingestion of nonsteroidal anti-inflammatory drugs (nsaids, including cox-2 selective anti-inflammatory drugs), ticlopidine, dipyridamole, warfarin or acenocoumarol
boolean
C0003211 (UMLS CUI [1])
C1257954 (UMLS CUI [2])
C0040207 (UMLS CUI [3])
C0012582 (UMLS CUI [4])
C0043031 (UMLS CUI [5])
C0000956 (UMLS CUI [6])
C1257954 (UMLS CUI [2])
C0040207 (UMLS CUI [3])
C0012582 (UMLS CUI [4])
C0043031 (UMLS CUI [5])
C0000956 (UMLS CUI [6])
Major surgery
Item
major surgical procedure within 1 month before enrolment
boolean
C0679637 (UMLS CUI [1])
Platelet count abnormal
Item
platelet count outside the 100 000 to 450 000/μl range
boolean
C0580317 (UMLS CUI [1])
Hematocrit procedure | Hemoglobin measurement
Item
hematocrit < 25% or haemoglobin < 100 g/l
boolean
C0018935 (UMLS CUI [1])
C0518015 (UMLS CUI [2])
C0518015 (UMLS CUI [2])
Dialysis Chronic Kidney Failure
Item
patient undergoing dialysis for chronic renal failure
boolean
C0011946 (UMLS CUI [1,1])
C0022661 (UMLS CUI [1,2])
C0022661 (UMLS CUI [1,2])